Document is current
Any future updates will be listed below
-
Authors
Petersson, Malin https://orcid.org/0000-0002-3449-0429
Wu, Jing
Berggren, Fredrik
Schager, Ingrid
Piehl, Fredrik
Brauner, Susanna
-
Funding
Funding for this research was provided by:
UCB
Karolinska Institute
- License Information
-
More Information
Article History
Received: 24 May 2025
Revised: 24 July 2025
Accepted: 25 July 2025
First Online: 7 August 2025
Declarations
:
: Anonymized data generated for the study are available from the corresponding author on reasonable request.
: MP and JW report no disclosures relevant to the manuscript. FB is an employee and stockholder of UCB, Copenhagen, Denmark. IS is an employee of UCB, Stockholm, Sweden. FP has received research grants from Denka, Janssen, Merck KGaA, Novartis, Pfizer and UCB unrelated to commercial products, and fees for serving on DMC in clinical trials with Lundbeck and Roche, and preparation of expert witness statement for Novartis. SB has received research grants from UCB and Janssen.
: The study was approved by the Stockholm regional ethics committee, Number 2016/828–31 and 2016/870–31. All participants gave oral consent.
